Calcium pyrophosphate deposition disease

T Pascart, G Filippou, F Lioté, S Sirotti… - The Lancet …, 2024 - thelancet.com
Calcium pyrophosphate deposition (CPPD) disease is a consequence of the immune
response to the pathological presence of calcium pyrophosphate (CPP) crystals inside …

[HTML][HTML] The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature …

E Cipolletta, G Filippou, CA Scirè, A Di Matteo… - Osteoarthritis and …, 2021 - Elsevier
Objective To examine and compare the accuracy of conventional radiography (CR) and
musculoskeletal ultrasonography (US) in the diagnosis of calcium pyrophosphate (CPP) …

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT) …

T Pascart, P Robinet, S Ottaviani, R Leroy… - The Lancet …, 2023 - thelancet.com
Background Acute calcium pyrophosphate crystal arthritis causes intense joint pain mainly
affecting older people. Because guidance and evidence remain scarce, management of this …

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis

M Krekeler, X Baraliakos, S Tsiami, J Braun - RMD open, 2022 - rmdopen.bmj.com
Background The crystal-induced calcium pyrophosphate deposition disease (CPPD)
clinically appearing as pseudogout differs from the mere radiographic finding of …

Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review

S Cowley, G McCarthy - Open Access Rheumatology: Research …, 2023 - Taylor & Francis
Abstract Calcium Pyrophosphate Dihydrate (CPPD) crystal-related arthropathies are a
common cause of acute and chronic arthritis caused by the deposition of calcium …

[HTML][HTML] Calcium pyrophosphate deposition (CPPD) disease–Treatment options

J Stack, G McCarthy - Best Practice & Research Clinical Rheumatology, 2021 - Elsevier
In contrast to gout, no disease-modifying therapies currently exist that reduce articular crystal
deposition of calcium pyrophosphate crystals (CPPs). Treatment is aimed at ameliorating the …

Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints

E Cipolletta, A Di Matteo, G Smerilli, M Di Carlo… - …, 2022 - academic.oup.com
Objective To explore the spectrum of articular and peri-articular ultrasound (US) findings at
metacarpophalangeal (MCP) joints in calcium pyrophosphate (CPP) deposition disease …

Recent advances in the therapeutic management of calcium pyrophosphate deposition disease

PV Voulgari, AI Venetsanopoulou, AA Drosos - Frontiers in Medicine, 2024 - frontiersin.org
Calcium pyrophosphate deposition (CPPD) disease is a form of crystal-induced arthropathy
that arises from the accumulation of calcium pyrophosphate crystals within joints and soft …

Outcomes of total hip arthroplasty in calcium pyrophosphate deposition disease patients

K Parperis, M Lampi, M Constantinou… - Seminars in Arthritis and …, 2023 - Elsevier
Objective We aim to examine the demographics, clinical characteristics, outcomes, and
resource utilization following total hip arthroplasty (THA) in patients with and without calcium …

The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease

A Altomare, A Corrado, N Maruotti, D Cici… - Molecular Biology …, 2021 - Springer
Abstract Calcium Pyrophosphate Crystal Deposition (CPPD) disease is characterized by the
deposition of calcium pyrophosphate crystals in the cartilage. In most cases, it can manifest …